Here you can find our clients' success stories. We are happy to celebrate our client's accomplishments; successful regulatory submissions, funding publications, and more. The largest source of pride comes from the achievements we've helped our clients reach. We've collected some noteworthy client information (from publicly available resources), and we're happy to introduce them here.
People who struggle with chronic constipation have a new drug-free option to help get things moving again.
It’s a first-of-its-kind capsule about the size of a regular pill – but instead of releasing medication after it’s swallowed, it vibrates to stimulate the colon.
Cancer is the number 1 cause of death in Israel (and also in most of the world). Now comes a company from Jerusalem that wants to treat the disease with the help of a highly innovative, particularly groundbreaking method.
Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™ - This designation applies to the treatment of Squamous Cell Carcinoma of the skin and oral cavity without curative standard of care.
Virility has received CE approval for EU marketing - A drug-free, patented, intimated single-use skin patch for the treatment of premature ejaculation.
AMA approves radiology-specific AI CPT code - The American Medical Association (AMA) has approved a Current Procedural Terminology (CPT) code specific to a radiology artificial intelligence (AI) algorithms.
Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™ - This designation applies to the treatment of Squamous Cell Carcinoma of the skin and oral cavity without a curative standard of care.
OBCT CD24 Ltd. - Possible COVID treatment found in Israel. EXO-CD24, an experimental inhaled medication developed at Tel Aviv Sourasky Medical Center, cured all 30 moderate-to-severe cases in a Phase I clinical trial.
Zebra wins FDA clearance for AI-based pleural effusion diagnosis tech. The deep-learning solution automatically identifies findings suggestive of pleural effusion based on CR, DR and DX scans.
FDA Clears ConTIPI Medical’s Pelvic Prolapse Treatment. The FDA cleared ConTIPI Medical’s ProVate, a device used to temporarily manage pelvic organ prolapse in women without surgery.
FDA Grants Theranica De Novo to Market First Smartphone-controlled Acute Migraine-relief Wearable Device Clinical Data Show 66.7% Pain Relief Response Within Two Hours.
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder.
HemoScreen™ Hematology Analyzer For Point Of Care, Receives FDA 510(K) Clearance. "The HemoScreen delivers lab accurate results and would be especially useful at physicians' offices, ER, ICU, Oncology clinics and remote locations," says Dr. Bransky.
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder. BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new era in brain disorder treatment.
Zebra Medical Vision Announces CE Approval Of Its Seventh AI Imaging Algorithm - Mammography Lesion Detection.
Oxitone Medical Receives FDA Clearance for Wrist-Sensor Pulse Oximetry Bracelet. Medical device and digital health startup Oxitone Medical launches the first to market wrist-sensor pulse oximetry bracelet to transform delivery of chronic disease home care.